Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.107706
Revised: May 22, 2025
Accepted: July 2, 2025
Published online: August 27, 2025
Processing time: 150 Days and 22.4 Hours
Proximal gastrectomy (PG) for gastric cancer requires a delicate balance between oncological radicality and postoperative quality of life to mitigate reflux complications. Although the Kamikawa anastomosis has gained attention for its theo
To comprehensively evaluate the efficacy, safety, and nutritional outcomes of the Kamikawa anastomosis in PG, thereby addressing a critical gap in surgical decision-making.
Following PRISMA guidelines, we systematically searched PubMed, Embase, and the Cochrane Library for studies on Kamikawa anastomosis after PG. Data were pooled using fixed- or random-effects models based on heterogeneity levels (I2 statistics). The risk of bias was evaluated using Risk of Bias in Non-randomized Studies of Interventions. The protocol was prospectively registered in PROS
Of 106 screened studies, 20 involving 2291 patients were included. Most studies (85%) originated from Japan, with a mean patient age of 54-73 years and a male predominance (68.1%). Overall pooled incidence of 30-day postoperative complications was 9.9% [95% confidence interval (95%CI): 6.8-12.9], with major complications (Clavien-Dindo grade ≥ III) occurring in 6.1% (95%CI: 4.6-7.7). Anastomosis-related complications were observed in 7.2% of cases, comprising leakage 1.8% (95%CI: 1.1-2.4), stenosis in 7.2% (95%CI: 5.8-8.5), and bleeding in 0.7% (95%CI: 0.1-1.2). Pooled incidence of reflux esophagitis was 4% (95%CI: 2.7-5.3) for all LA grades at 12-month follow-up, with 28.3% (95%CI: 14.7-41.9) of patients requiring regular proton pump inhibitor use. Operative outcomes demonstrated a pooled mean operative time of 349.5 minutes (95%CI: 331-380), estimated blood loss of 351.5 mL (95%CI: 264-495), and postoperative hospital stay of 12.3 days (95%CI: 11.5-13.1). Nutritional outcomes revealed 11.4% (95%CI: 10.6-12.2) body weight loss at one year. Comparative analyses showed equivalent safety profiles between the Kamikawa anastomosis and double-tract reconstruction but longer operative times (P < 0.001) compared with total gastrectomy.
These findings underscore the clinical viability of the Kamikawa anastomosis following PG, demonstrating favorable anti-reflux efficacy, acceptable incidence of anastomotic strictures, and preservation of nutritional status.
Core Tip: This systematic review and meta-analysis evaluates the efficacy, safety, and nutritional outcomes of Kamikawa anastomosis following proximal gastrectomy for gastric cancer. Our findings suggest that Kamikawa anastomosis offers favorable anti-reflux benefits with a low incidence of anastomotic complications, including leakage and stenosis. The procedure is associated with acceptable postoperative outcomes, although it requires longer operative times compared to total gastrectomy. Despite some nutritional loss, the overall clinical profile supports its viability as an option for proximal gastrectomy, addressing a significant gap in surgical decision-making for gastric cancer.